229 Users Online
A Detailed Analysis of the Urolithiasis Management Devices Market Based on Rising Urolithiasis Cases Worldwide, and Growing Demand for Effective Treatment Options
The global urolithiasis management devices market is forecast to expand at a CAGR of 5.1% and thereby increase from a value of US$1.6 Bn in 2023, to US$2.2 Bn by the end of 2030.
Urolithiasis Management Devices Market Size (2023E)
Projected Market Value (2030F)
Global Market Growth Rate (CAGR 2023 to 2030)
Historical Market Growth Rate (CAGR 2018 to 2022)
Medical equipment called urolithiasis management devices is used to identify, treat, and prevent kidney stones and urolithiasis. From minimally invasive techniques like ureteroscopy and percutaneous nephrolithotomy to non-invasive therapies like shock wave lithotripsy, these instruments are essential in the management of disorders associated with urinary stones. By providing safe and efficient urolithiasis care, they want to improve overall patient well-being, reduce symptoms, and make stone removal easier.
The market for urolithiasis management devices is expanding significantly as new technological developments result in the creation of cutting-edge stone management tools. Globally rising urolithiasis cases and a growing need for less intrusive therapies are driving the market's growth. Leading companies in the sector are concentrating on R&D to present innovative solutions, advance the market's development, and generate growth prospects.
Technological Advancements in Urolithiasis Management Devices
The market for urolithiasis management devices is being driven ahead in large part by the speed at which technology is developing. The field of treating urolithiasis has changed dramatically as a result of innovations like robotics, laser technology, and sophisticated imaging methods. Improved patient outcomes and faster recovery periods have been attained through increased precision in diagnosis and treatment methods combined with less invasiveness. Innovations in technology are not only improving the efficiency of procedures but also broadening the range of available treatments. This is drawing patients and healthcare professionals to these cutting-edge possibilities. The market is anticipated to increase steadily as manufacturers make R&D investments to remain at the forefront of technological innovation.
In addition, the increasing incidence of urolithiasis is a significant factor propelling the market for urolithiasis management devices. Globally, kidney stones are becoming more common due to changes in nutrition, lifestyle, and environmental factors. The need for urolithiasis management devices is being driven by the increase in urolithiasis cases, which calls for sophisticated and effective management solutions. The gadgets are essential for monitoring, follow-up care, and preventive actions in addition to the immediate requirement for stone removal. The market is expected to develop steadily as manufacturers align their strategies to address the increasing healthcare demands associated with kidney stone problems and healthcare systems work to satisfy the growing demand for effective urolithiasis therapy.
Concerns Around Reimbursement Procedures
Issues with reimbursement regulations significantly constrain the market for urolithiasis management devices. Widespread adoption of several modern urolithiasis management techniques is hampered by inadequate coverage and reimbursement. Financial obstacles may affect patients' and healthcare professionals' access to cutting-edge technologies. The intricacy of reimbursement procedures and disparities in policies among geographic areas present obstacles for producers, impacting market dynamics and possibly hindering the expansion of the urolithiasis management devices industry.
Barriers to Adoption Across Developing Markets
Adoption barriers are a significant issue for the urolithiasis management devices market, especially in developing nations. Insufficient knowledge, poor facilities, and disparate medical practices in these areas impede the broad adoption and application of cutting-edge urolithiasis treatment technologies. In order to overcome these obstacles, strategic measures, educational campaigns, and cooperative efforts are needed to raise awareness, provide the required infrastructure, and handle the particular difficulties that come with the adoption of urolithiasis management devices in developing healthcare ecosystems.
Expanding Adoption of Telemedicine in the Treatment of Urolithiasis
The market for urolithiasis management devices has a lot of potential due to the growing use of telemedicine. Patients with urolithiasis can benefit from remote consultations, follow-ups, and monitoring thanks to growing market for telemedicine, which makes healthcare more easily available and convenient. By integrating urolithiasis management devices with telehealth platforms, medical practitioners may evaluate patients' status from a distance and provide prompt interventions. In addition to improving patient participation, this move toward telemedicine creates opportunities for device makers to create and sell solutions specifically suited to this changing healthcare environment, which promotes expansion and broadens the availability of urolithiasis management services.
Moreover, companies in the market, the growing emphasis on research and development in the area of urolithiasis management devices offers a promising opportunity. The overall efficacy and safety of urolithiasis management are improved by ongoing attempts to adopt novel technology, such as smart devices for real-time monitoring and individualized treatment techniques. Urolithiasis management devices are becoming more and more prevalent due to partnerships between academic institutions and business leaders to investigate novel approaches. Manufacturers may leverage the growing need for better urolithiasis management choices, meet unmet demands, and tap into emerging trends by continuously emphasizing research and development. This opens up new potential for the industry.
Which Segment Leads based on the Treatment Type?
ESWL to be the Leading Treatment Type Category for its Non-invasive Approach, Quick Recovery, and Broad Acceptance
The treatment type segment is segmented into the extracorporeal shock wave lithotripsy (ESWL), percutaneous nephrolithotomy, intracorporeal lithotripsy, and others. The urolithiasis management devices market is dominated by ESWL, which is the largest segment due to its non-invasive nature, shortened recovery periods, and broad acceptance. This technique uses shock waves to disintegrate kidney stones, providing a less invasive option than surgery. The fastest-growing subset is intracorporeal lithotripsy, driven by advances in technology and a need for less intrusive procedures. This technique, which breaks up stones inside the urinary tract, is becoming more and more popular since it works well, causes less discomfort for patients, and speeds up their recovery—all of which are in line with the growing trend of less intrusive treatment choices.
Which of the Product Type Categories is at the Forefront?
Non-invasive SWL, and Advancements in Technology Underpin Dominance of Lithotripters
The product type segment is bifurcated into lithotripters, and ureteroscopes. Lithotripters are the industry leader in urolithiasis management devices, largely because of their essential function in non-invasive shock wave lithotripsy (SWL). Lithotripters are commonly used because they may break down kidney stones externally and offer a less intrusive and effective alternative to surgical procedures. The continued growth of this market is mostly due to the rising incidence of kidney stones and the ongoing improvements in lithotripsy technology.
The fastest-growing market is ureteroscopes, which might be attributed to the growing need for less invasive procedures. Precise removal of stones and therapeutic interventions are made possible by these devices, which provide direct visualization and action within the urinary tract. The urolithiasis management devices market segment is experiencing strong growth, which is partly attributed to advancements in optics and the integration of modern technologies in ureteroscope designs.
Which is the Most Prominent End User Sector?
Hospitals and Clinics at the Forefront
The end user segment is sub-segmented into hospitals, clinics, and ambulatory surgical centers (ASCs). Hospitals and clinics dominate the market for urolithiasis management devices because of their extensive infrastructure, capacity to serve a wide range of urological operations, and access to a diversified patient population. The high patient traffic and the availability of qualified medical personnel support this segment's supremacy. ASCs are the industry category with the quickest rate of growth, driven by the need for faster recovery, cost-effectiveness, and the growing trend toward outpatient operations. ASCs offer a practical and effective environment for managing urolithiasis, in line with patients' increasing desire for outpatient treatment and minimally invasive procedures.
North America's Primacy Receives Tailwinds from a Fair Reimbursement Environment
North America dominates the market for urolithiasis management devices because of factors such as a sophisticated healthcare system, a high incidence of urolithiasis cases, and active R&D. North America leads the urolithiasis management devices market due in part to its proactive adoption of cutting-edge medical technologies and its well-established healthcare system. Further driving market expansion in this area is a strong emphasis on patient-centric treatment, and a fair reimbursement environment.
Augmenting Healthcare Spending to Unlock Opportunities in East Asia
East Asia is the region with the quickest rate of growth because of rising healthcare spending, an aging population, and the uptake of cutting-edge medical technology. The rising market in East Asia is a result of rising awareness, bettering healthcare systems, and an increase in urolithiasis patients. East Asia's focus on improving healthcare facilities and the region's economic development make it a major growth driver in the urolithiasis management devices market.
The market for urolithiasis management devices is expected to rise steadily due to factors like rising urolithiasis cases, higher prevalence, and an increasing focus on minimally invasive techniques. The overall effectiveness of urolithiasis management devices is anticipated to improve with the ongoing development of diagnostic and treatment techniques and the incorporation of smart technology. The need for creative and effective urolithiasis management options is predicted to increase as healthcare systems around the world concentrate on enhancing patient outcomes and lowering treatment-related consequences.
Additionally, the market is anticipated to grow due to the growing use of telemedicine and the incorporation of these devices with digital healthcare platforms. The urolithiasis management devices market is anticipated to have a strong and dynamic future despite the persistence of problems such as reimbursement complexities and acceptance barriers in emerging economies. These issues are expected to be addressed through strategic initiatives and collaborative efforts.
A steady stream of cutting-edge technology and calculated manufacturer actions define the market's supply-side dynamics for urolithiasis management devices. Prominent industry participants are proactively conducting research and development to present innovative remedies that improve urolithiasis diagnosis, treatment, and prevention. This includes the creation of sophisticated ureteroscopes, lithotripters, and other specialized tools that provide better accuracy, less invasiveness, and better patient results. Another noteworthy development in urolithiasis management devices is the use of robotics, artificial intelligence, and data analytics. This allows medical personnel to access real-time insights and enhances the development of more effective and individualized treatment plans.
To increase their market share and diversify their product offerings, manufacturers are also concentrating on forming strategic alliances and working together with research institutes and healthcare facilities. These collaborations frequently entail the sharing of knowledge, assets, and patient data, which promotes creativity and speeds up the creation of cutting-edge urolithiasis treatment options. Maintaining a strong and dependable supply chain for urolithiasis management devices also heavily depends on efforts to optimize manufacturing procedures and guarantee regulatory compliance. In the end, improving patient care and treatment outcomes, supply-side dynamics are driven by a dedication to technological advancement, teamwork, and quality standards, guaranteeing that healthcare providers have access to cutting-edge tools for managing urolithiasis.
The market for urolithiasis management devices is highly competitive, with multiple major manufacturers vying for market share through innovative business practices, strategic alliances, and global growth. To introduce technologically improved products, major players in the market, including Allengers, Boston Scientific, BD, Cook Medical, ConMed, DirexGroup, and others, constantly spend on research and development. These businesses are creating new lithotripters, ureteroscopes, and other urolithiasis management products. They want to set themselves apart from the competition by providing upgraded features, including better imaging capabilities, quicker operation times, and more patient comfort.
In the market, strategic alliances, mergers, and acquisitions are commonplace as businesses aim to expand their geographic reach and range of products. Partnerships with academic research centers and healthcare facilities also give these businesses a competitive advantage by promoting innovation and hastening the creation of next-generation urolithiasis management products. An emphasis further impacts the competitive environment on quality control, regulatory compliance, and the capacity to offer extensive post-purchase assistance and training. The industry is being driven towards higher technological improvements and improved patient outcomes in the field of urolithiasis management by the intensifying rivalry among leading players as the market continues to evolve.
New Product Launch
Olympus Corporation introduced the Soltive SuperPulsed Laser System (Soltive Laser System) in June 2020. This novel thulium fiber laser application is intended for soft tissue and stone lithotripsy applications.
Market Impact: The market for urolithiasis management devices has benefited from the June 2020 launch of Olympus Corporation's Soltive SuperPulsed Laser System. This is because it has brought a novel use of thulium fiber laser technology, improved soft tissue and stone lithotripsy applications, and advanced treatment options.
(Source: Olympus Global)
MOSES 2.0, the latest iteration of the adaptable, proprietary MOSES platform for urological care, was introduced by Lumenis Ltd. in July 2020.
Market Impact: Technological advances in the management of urolithiasis will be marked by Lumenis Ltd.'s MOSES 2.0. These developments, which offer better precision and treatment alternatives for urology care, are anticipated to have a positive market impact. They feature improved capabilities in laser-based urological operations.
(Source: NS Medical Devices)
Calyxo hoovered up $32 million for a vacuum-assisted kidney stone fragment removal device in July 2022. The CVAC Aspiration System from Calyxo uses irrigation and aspiration in tandem to remove any residual pieces that may be left over after a kidney stone-breaking treatment.
Market Impact: The $32 million that Calyxo was able to secure for its CVAC Aspiration System-which uses vacuum-assisted technology to remove kidney stone fragments-marks a significant breakthrough in the treatment of urolithiasis. This novel tool is anticipated to enhance post-procedural results and stimulate demand for effective methods of removing leftover fragments after kidney stone treatments.
(Source: Mass Device)
2023 to 2030
Historical Data Available for
2018 to 2022
US$ Million for Value
Key Regions Covered
Key Countries Covered
Key Market Segments Covered
Key Companies Profiled
Customization & Pricing
Available upon request
By Treatment Type:
By Product Type:
By End User:
The market is anticipated to grow at a CAGR of 5.1% during the projected period.
The global urolithiasis management devices market was valued at US$1.6 billion in 2023.
The US held the largest market share in 2023.
Some of the prominent players in the market are Allengers, Boston Scientific, BD, Cook Medical, ConMed, DirexGroup, Dornier MedTech, KARL STORZ, Potent Optotronic, HealthTronics, Lumenis, Olympus, Richard Wolf, and Siemens Healthcare.
The intracorporeal lithotripsy segment is expected to grow at the fastest rate during the forecast period.